Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00897429 · ClinicalTrials.gov registry record
Studying Tissue Samples From Patients With Stage II Colon Cancer Treated on Clinical Trial CLB-9581
A clinical trial, sponsored by Alliance for Clinical Trials in Oncology.
- Completed
- Registry status
- 2,059
- Enrollment target
NCT00897429: Completed study, sponsored by Alliance for Clinical Trials in Oncology.
NCT00897429 is a clinical trial that has completed, run by Alliance for Clinical Trials in Oncology. The registered enrollment target is 2,059 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00897429 has completed, sponsored by Alliance for Clinical Trials in Oncology.
- COMPLETED
- Registry status
- 2,059 participants
- Enrollment target
Study Summary
This research trial studies tissue samples from patients with stage II colon cancer treated on Cancer and Leukemia Group B (CALGB)-9581 or CALGB-90903. Studying samples of tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in deoxyribonucleic acid (DNA) and identify biomarkers related to cancer. It may also help doctors understand how patients respond to treatment.
Primary Outcome
Using stratified analyses, effect modification by molecular alterations will be assessed. To maintain statistical power, body mass index and physical activity will be categorized into tertiles for the analyses of interactions with tumor molecular alterations. To assess whether the relative effect of an exposure differs according to the presence of the molecular alteration, tests for statistical interaction will be performed by entering into the model the cross-product term of the molecular alter
Interventions
- PROCEDURE laboratory biomarker analysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,059 participants |
| Start Date | 2007-07 |
| Est. Completion | 2019-02 |
What the finished NCT00897429 record still lists
NCT00897429 is an observational study that tracks outcomes without assigning an intervention. Its 2,059 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which laboratory biomarker analysis is the first listed.
NCT00897429 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00897429 about?
NCT00897429 is a clinical study titled "Studying Tissue Samples From Patients With Stage II Colon Cancer Treated on Clinical Trial CLB-9581". This research trial studies tissue samples from patients with stage II colon cancer treated on Cancer and Leukemia Group B (CALGB)-9581 or CALGB-90903. Studying samples of tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in deoxyribonucleic acid...
What is the current status of trial NCT00897429?
This trial is currently completed. The enrollment target is 2,059 participants. The study started on 2007-07. Estimated completion is 2019-02.
What interventions are being tested in trial NCT00897429?
The interventions under investigation include: laboratory biomarker analysis (PROCEDURE).
Who is sponsoring clinical trial NCT00897429?
This trial is sponsored by Alliance for Clinical Trials in Oncology, which has 446 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04871542 · 2,062 participants
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
- NCT06521944 · 2,062 participants
RSV Vaccine Pregnancy Registry
- NCT07168993 · 2,063 participants · NA
Evaluate the Clinical Performance of the Flow Cytometry - FlowPath Lung Test as a Sensitive and Specific Non-invasive Diagnostic of Sputum Samples to Identify/Detect the Presence of Lung Cancer in High-risk Individuals Who Have Existing Lung Nodules, 6 to <30 mm in Diameter, Determined by LDCT.
- NCT06666192 · 2,067 participants · NA
The Ohio State University (OSU) SCREEN Community Program
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia